Clinical Trial

Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-06.
Trial Details
NCT Number NCT07526051
Lead Sponsor Foundation University Islamabad
Conditions Lower Cross Syndrome
Enrollment 72 participants
Start Date 2026-05-20
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-20